However, unlike in CLL, where BCL-2 mutations, such as G101V, are common, we did not detect BCL-2 mutations in our resistant samples, suggesting that genetic alterations in BCL-2 are not a common resistance mechanism [21]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.